Talha Badar

93PUBLICATIONS
325CO-AUTHORS
Haematological tumoursGene and molecular therapyRegenerative medicine (incl. stem cells)HaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (93)

|Sep 28, 2026
Clinical and molecular characteristics of clonal monocytosis with and without cytopenia(s).

|Sep 18, 2026
Venetoclax Plus Hypomethylating Agent for 7- Versus 14- Versus 21- Versus 28-Day Cycles in Newly-Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk-Stratified Analysis in 540 Patients.

|Sep 15, 2026
Menin Inhibitors in Acute Myeloid Leukemia: Clinical Integration, Resistance, and the Path Beyond Monotherapy.

|Sep 15, 2026
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

|Aug 31, 2026
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

Pageof 16

Frequent Collaborators

34 joint publications

Naseema Gangat

32 joint publications

Mark R Litzow

31 joint publications

Mrinal Patnaik

29 joint publications

Aref Al-Kali